Remdesivir Demonstrates Further Promise

June 18, 2020

Remdesivir Demonstrates Further Promise

Gilead Science’s antiviral COVID treatment, remdesivir, effectively prevents lung damage in macaque monkeys infected with coronavirus, according to findings published in Nature. Yourway offers direct-to-patient services to help trials continue to run and provide convenience for patients when they can’t leave their homes.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?